Literature DB >> 24933007

Abnormal hepatocellular mitochondria in methylmalonic acidemia.

Yael Wilnai1, Gregory M Enns, Anna-Kaisa Niemi, John Higgins, Hannes Vogel.   

Abstract

Methylmalonic acidemia (MMA) is one of the most frequently encountered forms of branched-chain organic acidemias. Biochemical abnormalities seen in some MMA patients, such as lactic acidemia and increased tricarboxylic acid cycle intermediate excretion, suggest mitochondrial dysfunction. In order to investigate the possibility of mitochondrial involvement in MMA, we examined liver tissue for evidence of mitochondrial ultrastructural abnormalities. Five explanted livers obtained from MMA mut(0) patients undergoing liver transplantation were biopsied. All patients had previous episodes of metabolic acidosis, lactic acidemia, ketonuria, and hyperammonemia. All biopsies revealed a striking mitochondriopathy by electron microscopy. Mitochondria were markedly variable in size, shape, and conformation of cristae. The inner matrix appeared to be greatly expanded and the cristae were diminutive and disconnected. No crystalloid inclusions were noted. This series clearly documents extensive mitochondrial ultrastructure abnormalities in liver samples from MMA patients undergoing transplantation, providing pathological evidence for mitochondrial dysfunction in the pathophysiology of MMA mut(0). Considering the trend to abnormally large mitochondria, the metabolic effects of MMA may restrict mitochondrial fission or promote fusion. The correlation between mitochondrial dysfunction and morphological abnormalities in MMA may provide insights for better understanding and monitoring of optimized or novel therapeutic strategies.

Entities:  

Keywords:  Methylmalonic acidemia; electron microscopy; liver biopsy; mitochondria

Mesh:

Year:  2014        PMID: 24933007     DOI: 10.3109/01913123.2014.921657

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  10 in total

1.  FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.

Authors:  Irini Manoli; Justin R Sysol; Madeline W Epping; Lina Li; Cindy Wang; Jennifer L Sloan; Alexandra Pass; Jack Gagné; Yiouli P Ktena; Lingli Li; Niraj S Trivedi; Bazoumana Ouattara; Patricia M Zerfas; Victoria Hoffmann; Mones Abu-Asab; Maria G Tsokos; David E Kleiner; Caterina Garone; Kristina Cusmano-Ozog; Gregory M Enns; Hilary J Vernon; Hans C Andersson; Stephanie Grunewald; Abdel G Elkahloun; Christiane L Girard; Jurgen Schnermann; Salvatore DiMauro; Eva Andres-Mateos; Luk H Vandenberghe; Randy J Chandler; Charles P Venditti
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Gene Therapy for Methylmalonic Acidemia: Past, Present, and Future.

Authors:  Randy J Chandler; Charles P Venditti
Journal:  Hum Gene Ther       Date:  2019-08-16       Impact factor: 5.695

3.  Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.

Authors:  Randy J Chandler; Matthew C LaFave; Gaurav K Varshney; Niraj S Trivedi; Nuria Carrillo-Carrasco; Julien S Senac; Weiwei Wu; Victoria Hoffmann; Abdel G Elkahloun; Shawn M Burgess; Charles P Venditti
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

Review 4.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

5.  Insights into the molecular mechanisms of methylmalonic acidemia using microarray technology.

Authors:  Lianshu Han; Shengnan Wu; Feng Han; Xuefan Gu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers.

Authors:  Marianna Caterino; Randy J Chandler; Jennifer L Sloan; Kenneth Dorko; Kristina Cusmano-Ozog; Laura Ingenito; Stephen C Strom; Esther Imperlini; Emanuela Scolamiero; Charles P Venditti; Margherita Ruoppolo
Journal:  Mol Biosyst       Date:  2016-02

Review 7.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

8.  Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.

Authors:  F Molema; E H Jacobs; W Onkenhout; G C Schoonderwoerd; J G Langendonk; Monique Williams
Journal:  J Inherit Metab Dis       Date:  2018-08-29       Impact factor: 4.982

9.  TAT-MTS-MCM fusion proteins reduce MMA levels and improve mitochondrial activity and liver function in MCM-deficient cells.

Authors:  Tal Erlich-Hadad; Rita Hadad; Anat Feldman; Hagar Greif; Michal Lictenstein; Haya Lorberboum-Galski
Journal:  J Cell Mol Med       Date:  2017-12-19       Impact factor: 5.310

Review 10.  Altered Redox Homeostasis in Branched-Chain Amino Acid Disorders, Organic Acidurias, and Homocystinuria.

Authors:  Eva Richard; Lorena Gallego-Villar; Ana Rivera-Barahona; Alfonso Oyarzábal; Belén Pérez; Pilar Rodríguez-Pombo; Lourdes R Desviat
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.